MIGS

ELIOS is the first clinically-validated excimer laser MIGS, which uses high precision, non-thermal, laser ablation to create 10 microchannels in the trabecular meshwork to enhance physiological outflow into Schlemm’s canal whilst preserving angle anatomy.

Two-handed MIGS is now possible for the first time!

Surgeons can now attach the gonio lens to the microscope rather than having to hold the gonio lens with one hand. This gives them two free hands for the surgery.

Learn more at: www.oculussurgical.com/migs.

The iTrack is a restorative, minimally-invasive approach to glaucoma. It is tissue-sparing, offering the physician early intervention, whilst maximising patient quality-of-life.

• Unique illuminated tip, providing continuous location feedback
• Delivers approx. +100µl of OVD over 360° of Sclemm’s canal
• 360° catheterisation
• Adjustable OVD delivery.

The iTrack™ Advance combines the clinically proven iTrack™ canaloplasty microcatheter with an innovative handheld injector design.

• Suitable for mild-moderate glaucoma (and a crucial element in the success of ABiC)
• Unique illuminated ‘spatulated’ cannula tip can be used to create micro-goniotomy & allows easy insertion to Schlemm’s canal
• An actuator used to extend/retract the microcatheter.

The OMNI® Surgical System from Sight Sciences is the first and only MIGS device indicated for canaloplasty and trabeculotomy that allows you to:

Perform two implant-free MIGS procedures, standalone or combined with cataract surgery, Target all three points of resistance to restore natural aqueous outflow, Deliver sustained, long-term IOP reduction with the potential to reduce or eliminate medication.